ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Aditxt Inc

Aditxt Inc (ADTX)

0,46531
-0,02469
( -5,04% )
Aktualisiert: 20:24:51

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,46531
Gebot
0,4668
Fragen
0,474
Volumen
718.003
0,4529 Tagesbereich 0,4879
0,4529 52-Wochen-Bereich 380,00
Marktkapitalisierung
Handelsende
0,49
Handelsbeginn
0,48
Letzte Trade
12
@
0.4669
Letzter Handelszeitpunkt
20:24:32
Finanzvolumen
US$ 339.077
VWAP
0,47225
Durchschnittliches Volumen (3 Mio.)
3.837.409
Ausgegebene Aktien
134.717
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-242,74
Erlöse
645k
Nettogewinn
-32,7M

Über Aditxt Inc

Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantatio... Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Camden, Delaware, USA
Gegründet
-
Aditxt Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ADTX. The last closing price for Aditxt was US$0,49. Over the last year, Aditxt shares have traded in a share price range of US$ 0,4529 to US$ 380,00.

Aditxt currently has 134.717 shares in issue. The market capitalisation of Aditxt is US$66.011,33 . Aditxt has a price to earnings ratio (PE ratio) of 0.00.

ADTX Neueste Nachrichten

Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today shared an important milestone for its target...

Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for...

Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today announced the hosting of an update and Q&A...

Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives

Aditxt, Inc. (“Aditxt” or the “Company”) (NASDAQ: ADTX), a social innovation platform dedicated to accelerating promising health innovations, today announced the appointment of Sylvia Hermina to...

Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, today announced the achievement of a key milestone...

Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time

Event to Focus on the Status of the Acquisition, Plans Post-Acquisition for Evofem, and Q&A Aditxt, Inc. (“Aditxt” or the “Company”) (NASDAQ: ADTX), a social innovation platform dedicated to...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.23969-33.99858156030.7050.7050.452945072490.55146341CS
4-1.09469-70.17243589741.561.85990.452940147250.94472535CS
12-43.33469-98.937648401843.846.80.452938374094.12999801CS
26-93.13469-99.502873931693.61080.4529294755426.19091645CS
52-268.33469-99.8268936012268.83800.4529190570367.48197709CS
156-3631.53469-99.98718860133632455840.452921985581073.99532173CS
260-8447.53469-99.99449206918448455840.452922831892476.74823753CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ZCARZoomcar Holdings Inc
US$ 13,50
(234,99%)
24,56M
BNOXBionomics Ltd
US$ 0,5231
(173,53%)
452,46M
BJDXBluejay Diagnostics Inc
US$ 0,1558
(113,72%)
750,5M
ALBTAvalon GloboCare Corporation
US$ 3,4102
(52,24%)
31,54M
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 63,75
(45,85%)
695,08k
VRCAVerrica Parmaceuticals Inc
US$ 0,848
(-40,70%)
2,72M
MQMarqeta Inc
US$ 3,545
(-40,42%)
58,91M
LILMLilium NV
US$ 0,0534
(-35,27%)
52,08M
VSTEVast Renewable Ltd
US$ 4,67
(-30,81%)
2,09M
NUWENewellis Inc
US$ 1,99
(-29,18%)
5,03M
BJDXBluejay Diagnostics Inc
US$ 0,1545
(111,93%)
750,47M
BNOXBionomics Ltd
US$ 0,52
(171,91%)
459,13M
ELABElevai Labs Inc
US$ 0,0231
(14,93%)
418,56M
XTIAXTI Aerospace Inc
US$ 0,0447
(-10,24%)
315,61M
SQQQProShares UltraPro Short QQQ
US$ 7,26
(-3,46%)
122,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock